This document discusses the Collaboration for Outcomes Using Social Media in Oncology (COSMO), a group of oncologists and hematologists who are exploring the use of social media in cancer care. COSMO aims to define best practices for social media use, conduct research on its benefits and limitations, and enhance communication within the oncology community and between doctors and patients. Some of COSMO's accomplishments include promoting hashtags for online discussions, publishing reviews on social media risks/benefits, and conducting qualitative Twitter chat research to understand patient needs. The collaboration is important because patients often look to doctors for cancer information online.
Radiation Nation - Frugal, Global and Mobile CollaborationMatthew Katz
How do we mobilize people to improve cancer care? This talk at Dana Farber Cancer Institute explores how we can harness amateurs to accomplish more using digital communications globally.
Presentation at the Philippine National Health Research Week preconference meeting: Rallying Communicators for Science, Technology, and Innovation in Health | Society of Health Research Communicators (SHARE). 22 August 2017, Hotel Jen, Manila.
Digital communications are changing how we share health information. Are social media compatible with academic medicine and oncology?
This is a talk given at Brigham & Women's Hospital to the Harvard Radiation Oncology Program residents and staff on December 19 2014. It is intended as a survey rather than definitive presentation, highlighting the need for more research.
The rise of online fake news on social media highlights an increasing problem. This talk, given at University of Michigan, explores why health professionals have a professional obligation to ensure patients get accurate, understandable health information.
Radiation Nation - Frugal, Global and Mobile CollaborationMatthew Katz
How do we mobilize people to improve cancer care? This talk at Dana Farber Cancer Institute explores how we can harness amateurs to accomplish more using digital communications globally.
Presentation at the Philippine National Health Research Week preconference meeting: Rallying Communicators for Science, Technology, and Innovation in Health | Society of Health Research Communicators (SHARE). 22 August 2017, Hotel Jen, Manila.
Digital communications are changing how we share health information. Are social media compatible with academic medicine and oncology?
This is a talk given at Brigham & Women's Hospital to the Harvard Radiation Oncology Program residents and staff on December 19 2014. It is intended as a survey rather than definitive presentation, highlighting the need for more research.
The rise of online fake news on social media highlights an increasing problem. This talk, given at University of Michigan, explores why health professionals have a professional obligation to ensure patients get accurate, understandable health information.
The 2014 MDigitalLIfe Social Oncology Project ReportW2O Group
One year ago, the Social Oncology Project 2013 report was published ahead of the American Society of Clinical Oncology’s annual meeting, for the first time quantifying the scope and nature of digital conversations about oncology - over 16 million of them.
In 2014, we're focusing in on the trends in those cancer conversations, paying particular attention to those we've culled from the MDigitalLife data set – the world's first and only database that maps physicians' digital properties to their official government registries.
Presentation by Mike Groszmann of University College London Hospitals NHS Foundation Trust at the London Cancer Children, Teenager and Young Adults Study Day, held on 25 July 2013.
In these slides, I briefly outline how the Internet is changing healthcare by empowering the consumer and the e-patient. We look at data and examples from the USA and Europe, and consider the impact of ratings websites, online health records, and the way in which doctors are responding to the e-patient.
My talk 5/19/2016 for the Massachusetts Medical Society's Residents Fellows Section (RFS) annual meeting in Boston. Many doctors want to know how to get involved online. I discuss why to get online and highlight MMS' recently updated guidelines.
Webinar presentation at the RED8 postgraduate course of the Department of Internal Medicine of Chong Hua Hospital Cebu in partnership with the RED Medical Foundation, 11 July 2021.
Introduction of "Let's Talk about Chlamydia" panel by Tom Beall, Managing Director, Global Director of Social Marketing, Ogilvy Public Relations Worldwide
I was pleased to be involved in some of the interviews that happened when the authors were planning this report... and then to be asked to write the Preface was an honour. Since publication I am not myself very aware of the impact of it, and I think this is such an important piece of work, that it deserves publicity as widely as possible. Hence uploaded here
Ruth Buzi of the Baylor College of Medicine Teen Health Clinic higlights an array of social media strategies used to enhance health promotion among youth and young adults. Presented at YTH Live 2014 session "The Strength of Social Media."
Given the ubiquity and speed of text messaging, texting may be the most effective way to deliver important health information to Native teens and young adults, but does it really change behavior? The team designed a series of theory-based text messages to promote condom use and testing for sexually transmitted infections, and then carried out formative research activities with 60 American Indian and Alaska Native youth to refine the implementation plan and tailor the intervention messages to the needs and concerns of Native teens. To evaluate the impact of the behavioral intervention, delivered entirely via text message (including participant recruitment, consent, intervention messaging, and pre-post surveys) 408 youth from across Indian Country were successfully enrolled. Results showed positive changes in attitudes and behaviors towards condom use, and intention and behavior toward STI testing. More than 40% of those who had not been tested recently, got tested.
Support & information for radiotherapy patients: how can social media help?KimMeeking
Slides from my presentation looking at social media for patient benefit and also for healthcare professionals in the field of cancer and radiation therapy.
Presented at the UK Radiological and Radiation Oncology Congress (UKRCO), Liverpool, July 2nd 2018
The 2014 MDigitalLIfe Social Oncology Project ReportW2O Group
One year ago, the Social Oncology Project 2013 report was published ahead of the American Society of Clinical Oncology’s annual meeting, for the first time quantifying the scope and nature of digital conversations about oncology - over 16 million of them.
In 2014, we're focusing in on the trends in those cancer conversations, paying particular attention to those we've culled from the MDigitalLife data set – the world's first and only database that maps physicians' digital properties to their official government registries.
Presentation by Mike Groszmann of University College London Hospitals NHS Foundation Trust at the London Cancer Children, Teenager and Young Adults Study Day, held on 25 July 2013.
In these slides, I briefly outline how the Internet is changing healthcare by empowering the consumer and the e-patient. We look at data and examples from the USA and Europe, and consider the impact of ratings websites, online health records, and the way in which doctors are responding to the e-patient.
My talk 5/19/2016 for the Massachusetts Medical Society's Residents Fellows Section (RFS) annual meeting in Boston. Many doctors want to know how to get involved online. I discuss why to get online and highlight MMS' recently updated guidelines.
Webinar presentation at the RED8 postgraduate course of the Department of Internal Medicine of Chong Hua Hospital Cebu in partnership with the RED Medical Foundation, 11 July 2021.
Introduction of "Let's Talk about Chlamydia" panel by Tom Beall, Managing Director, Global Director of Social Marketing, Ogilvy Public Relations Worldwide
I was pleased to be involved in some of the interviews that happened when the authors were planning this report... and then to be asked to write the Preface was an honour. Since publication I am not myself very aware of the impact of it, and I think this is such an important piece of work, that it deserves publicity as widely as possible. Hence uploaded here
Ruth Buzi of the Baylor College of Medicine Teen Health Clinic higlights an array of social media strategies used to enhance health promotion among youth and young adults. Presented at YTH Live 2014 session "The Strength of Social Media."
Given the ubiquity and speed of text messaging, texting may be the most effective way to deliver important health information to Native teens and young adults, but does it really change behavior? The team designed a series of theory-based text messages to promote condom use and testing for sexually transmitted infections, and then carried out formative research activities with 60 American Indian and Alaska Native youth to refine the implementation plan and tailor the intervention messages to the needs and concerns of Native teens. To evaluate the impact of the behavioral intervention, delivered entirely via text message (including participant recruitment, consent, intervention messaging, and pre-post surveys) 408 youth from across Indian Country were successfully enrolled. Results showed positive changes in attitudes and behaviors towards condom use, and intention and behavior toward STI testing. More than 40% of those who had not been tested recently, got tested.
Support & information for radiotherapy patients: how can social media help?KimMeeking
Slides from my presentation looking at social media for patient benefit and also for healthcare professionals in the field of cancer and radiation therapy.
Presented at the UK Radiological and Radiation Oncology Congress (UKRCO), Liverpool, July 2nd 2018
Digital communications bring opportunity and risk to the therapeutic relationship. Doctors and other health professionals can learn to collaborate in person and online to protect informed decision making. Modified slightly from a talk August 8 2019 at Brigham & Women's Hospital/Dana-Farber Cancer Institute.
MyHealthTeams -- Innovations in Consumer EngagementJ. Michelle Cox
Insights into the impact of strong social connections on health outcomes -- driven by social networks for people living with chronic conditions and an increasing focus on patient engagement within the pharmaceutical industry.
Social media is a broad term that encompasses many Internet
based sites through which online-users communicate and disseminate information. Social media networks, such as Facebook, Twitter, and YouTube, are redefining the concept of community as online users can now exchange ideas, messages, videos, and other forms of usercontent within seconds
Doing Good: How SoMe can enhance medical education. GR Nov. 28, 2014Jenny Laidlaw
Grand Rounds presentation Nov. 28, 2014 for the University Health Network Department of Psychiatry. Presents the opportunities and challenges of using social media for medical education, including personal examples.
Digitally powered participant-directed studies- Strategy for Decentralized Ca...Levi Shapiro
Digitally powered participant-directed studies. A Strategy for Decentralized Care. The Evolution of the Digital Patient Experience in Oncology & opportunities for Human Augmented Intelligence and Touch. Outlne: Precedent and example; Opportunities for Artificial Intelligence and/or Machine Learning? The human touch to augment technology; Challenges from a behavioral economics standpoint; Future directions. Digitally powered participant-directed studies are the
right direction and may be the new reality. Patient Symptoms During Their Cancer Journey. We must shift our focus to the ‘other’ 99% of time. Patient centricity unrestricted by provider encounters. Patient Generated Health Data. Evolving the Digital Patient Experience in Oncology. AI in Health & Medicine. TREATING THE WHOLE PERSON; Health coaching to address social determinants to: Solve the 4000-hour problem; Keep patients healthy at home; Close care gaps between clinic visits; Motivate healthy behavior changeto drive better outcomes. Digital Health Possibilities for Community-Based Support. Insights from a Pilot of Digital Health Coaching. Pilot Study Data. Outcomes of a Pilot Study Exploring the Role of Digital Health Coaching for Men with Prostate Cancer. Data, Healthcare and Technology...REMEMBER THAT THERE ARE SILOS INSIDE OF EACH OF THESE SILOS – THEY ARE THEMSELVES NOT MONOLITHS. EMPHASIS SHOULD BE THAT WE ARE NOT ONLY CREATING A BRIDGE TO OPEN COMMUNICATION.
WE ARE ALSO CREATING A NEW PERSON WHO HAS EXPERTISE IN ALL AREAS BROADLY – NOT ONLY JUST THESE 3.
This presentation was provided by Anne Stone of TBI Communications during the NISO Training Thursday event, Metrics Case Studies, held on December 14, 2017.
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
Yearly presentation as part of the Johns Hopkins course: A New View: Improving Public Health through Innovative Social and Behavioral Tools and Approaches. Delivered on june 21, 2018.
This slides wer presented at the Medicine 2.0 conference at Stanford University on 09.17.11 and include data that was collected as part of a research collaboration b/w Bob Miller (Hopkins), Bryan Vartabedian (Baylor), Molly Wasko (UAB), and the team at CE Outcomes. This research was funded in part by the Medical Education Group at Pfizer, Inc.
Connectivity, Collaboration, and Disruption: Social Media and the OncologistRobert Miller
On 2/4/14, I presented a talk at Memorial Sloan-Kettering Cancer Center "Connectivity, Collaboration, and Disruption: Social Media and the Oncologist." I created a special hashtag - #msk_hcsm14 and used it to schedule a series of tweets to go out during the talk with some of my references.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Surgical Site Infections, pathophysiology, and prevention.pptx
Clinicians on Social Media: A Call for Engagement (D. Dizon)
1. Don S. Dizon MD
Director, Women’s Cancers, Lifespan Cancer Institute
Director, Medical Oncology, Rhode Island Hospital
Associate Professor of Medicine, Alpert Medical School of Brown
University
Clinicians on Social
Media: A Call for
Engagement
2. Clinician Involvement: The challenge
McGowan BS, Wasko M, Vartabedian BS, Miller RS, Freiherr DD, Abdolrasulnia M. J Med Internet Res 2012; 14:e117
5. Oncologists on Twitter: US use versus ASCO AM
• 2013: 82,323 cancer related tweets from 4,155 US docs
United States:
• 2012 11,158 tweets from 2,062 participants
• 2013 17,450 tweets from 3,586 participants
• 2014 45,843 tweets from 8,770 participants
ASCO Annual meeting
ASCO: 12,100 US heme-oncs in 2016
6. How do we engage our peers?
Provide evidence that it will be of professional benefit?
Foster altruism
Engage reciprocally
Nurture collectivism
8. Digital
Engagement:
The SWOG
Definition
Apps
Online videos
Social media platforms, pages, and
campaigns
Interactive webpages
Wearable devices
Web-based videoconferencing
Any tool that
allows for two-
way interaction
Email
Web–based surveys (eg, Survey
Monkey)
Simple static, web pages (info only)
Examples of
digital tools not
under this
definition
9. Mission of DE Committee
Enhance communication
within our SWOG
community
Improve connections
between the SWOG and
the public
Improve the
research enterprise
11. DE Review
Projects testing a digital
tool as a primary or
secondary objective
• Clarity in hypothesis
• Well delineated objectives
• Sound methodology
• Analytic Plan
Criteria:
12. Who is
COSMO?
• Don Dizon (Providence)
• Matt Katz, Jennifer Kesselheim
(Boston)
EAST
• Deanna Attai (Los Angeles)
• Mina Sedrak (Duarte)WEST
• Michael Fisch (Houston)
• David Graham (Raleigh)
• MJ Markham (Gainesville)
SOUTH
• Mike Thompson (Racine, WI)
• Patricia Anderson (Ann Arbor)
• Nathan Pennell (Cleveland)
CENTRAL
14. What has
COSMO done
Promoted hashtags for online use
• Katz MS, Utengen A, Anderson PF, Thompson MA, Attai DJ, Johnston C, Dizon DS.
Disease-Specific Hashtags for Online Communication About Cancer Care. JAMA
Oncol. 2016 Mar;2(3):392-4. PMID: 26539640
Crafted Reviews for oncologists and hematologists
• Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J, Markham MJ,
Pennell NA, Sedrak MS, Thompson MA, Utengen A, Dizon DS; Collaboration for
Outcomes on Social Media in Oncology (COSMO). Risks and benefits of Twitter use
by hematologists/oncologists in the era of digital medicine. Semin Hematol. 2017
Oct;54(4):198-204. PMID: 29153081
• Thompson MA, Ahlstrom J, Dizon DS, Gad Y, Matthews G, Luks HJ, Schorr A.
Twitter 101 and beyond: introduction to social media platforms available to
practicing hematologist/oncologists. Semin Hematol. 2017 Oct;54(4):177-183.
PMID: 29153077
• Sedrak MS, Dizon DS, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim JC,
Miller RS, Thompson MA, Utengen A, Attai DJ; Collaboration for Outcomes on
Social Media in Oncology (COSMO). The emerging role of professional social media
use in oncology. Future Oncol. 2017 Jun;13(15):1281-1285. PMID: 28589770
• Attai DJ, Sedrak MS, Katz MS, Thompson MA, Anderson PF, Kesselheim JC, Fisch
MJ, Graham DL, Utengen A, Johnston C, Miller RS, Dizon DS; Collaboration for
Outcomes on Social Media in Oncology (COSMO). Social media in cancer care:
highlights, challenges & opportunities. Future Oncol. 2016 Jul;12(13):1549-52.
PMID: 27025657
15. What has
COSMO done
Qualitative Research
• TL Hagan, K Nauth-Shelley, MA Thompson, DJ
Attai, MS Katz, D Graham, D Sparacio, C Lizaso,
A Utengen, DS Dizon. The needs of women
treated for ovarian cancer: Results from a
#Gyncsm Twitter chat. J Patient-Centered Res
and Rev 2017
